Transforming Growth Factor β Stimulates the Human Immunodeficiency Virus 1 Enhancer and Requires NF-κB Activity

REFERENCES

• Arsura, M., M. Wu, and G. E. Sonenshein 1996. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκB alpha. Immunity 5: 31–40.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and T. Henkel 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141–179.
   PubMed Web of Science ®Google Scholar
• Bassing, C. H., J. M. Yingling, D. J. Howe, T. Wang, W. W. He, M. L. Gustafson, P. Shah, P. K. Donahoe, and X-F. Wang 1994. A transforming growth factor β type 1 receptor that signals to activate gene expression. Science 263: 87–89.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., and D. Baltimore 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782–784.
   PubMed Web of Science ®Google Scholar
• Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Makham, and N. E. Fusenig 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761–771.
   PubMed Web of Science ®Google Scholar
• Carcamo, J., F. M. B. Weis, F. Ventura, R. Wieser, J. L. Wrana, L. Attisano, and J. Massague 1994. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14: 3810–3821.
   PubMed Web of Science ®Google Scholar
• Cupp, C., J. P. Taylor, K. Khalili, and S. Amini 1993. Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8: 2231–2236.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. Panus, D. J. Howe, Y. Xiong, and X.-Y. Wang 1995. TGF-β mediated growth inhibition is associated with induction of the cyclin-dependent kinase inhibitor, p21. Proc. Natl. Acad. Sci. USA 92: 5545–5549.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Yu, and X.-F. Wang 1995. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270: 28623–28628.
   PubMedGoogle Scholar
• Datto, M. B., and X.-F. Wang. Unpublished data.
   Google Scholar
• de Martin, R., B. Haendler, R. Hofer-Warbinek, H. Gaugitsch, M. Wrann, H. Schlusener, and J. M. Seifert 1987. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J. 6: 3673–3677.
   PubMed Web of Science ®Google Scholar
• Espevik, T., I. S. Figari, G. E. Ranges, Palladino M. A., Jr. 1988. Transforming growth factor-β1 (TGF-β1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-β1 and TGF-β2, and recombinant human TGF-β1. J. Immunology 140: 2312–2316.
   PubMed Web of Science ®Google Scholar
• Feng, X. H., and R. Derynck 1996. Ligand-independent activation of transforming growth factor (TGF) β signaling pathways by heteromeric cytoplasmic domains of TGF-β receptors. J. Biol. Chem. 271: 13123–13129.
   PubMedGoogle Scholar
• Flanagan, W. M., B. Corthesy, R. J. Bram, and G. R. Crabtree 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352: 803–807.
   PubMed Web of Science ®Google Scholar
• Javahery, R., A. Khachi, K. Lo, B. Zenzie-Gregory, and S. T. Smale 1994. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14: 116–127.
   PubMed Web of Science ®Google Scholar
• Jones, K. A. 1993. Tat and the HIV-1 promoter. Curr. Opin. Cell Biol. 5: 461–468.
   PubMedGoogle Scholar
• Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. Jakowlew, M. B. Sporn, and A. S. Fauci 1986. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137: 3855–3860.
   PubMed Web of Science ®Google Scholar
• Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037–1050.
   PubMed Web of Science ®Google Scholar
• Kekow, J., W. Wachsman, J. A. McCutchan, M. Cronin, D. A. Carson, and M. Lotz 1990. Transforming growth factor β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 87: 8321–8325.
   PubMed Web of Science ®Google Scholar
• Kinoshita, S., L. Su, M. Amano, L. A. Timmerman, H. Kaneshima, and G. P. Nolan 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6: 235–244.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260: 536–539.
   PubMed Web of Science ®Google Scholar
• Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770–774.
   PubMed Web of Science ®Google Scholar
• Lazdins, J. K., T. Klimkait, E. Alteri, M. Walker, K. Woods-Cook, D. Cox, and G. Bilbe 1991. TGF-β: upregulator of HIV replication in macrophages. Res. Virol. 142: 239–242.
   PubMedGoogle Scholar
• Lazdins, J. K., T. Klimkait, K. Woods-Cook, M. Walker, E. Alteri, D. Cox, and N. Cerletti 1991. In vitro effect of transforming growth factor-β on pregression of HIV-1 infection in primary mononuclear phagocytes. J. Immunol. 147: 1201–1207.
   PubMed Web of Science ®Google Scholar
• Letterio, J. J., A. G. Geiser, A. B. Kulkarni, N. S. Roche, M. B. Sporn, and A. B. Roberts 1994. Maternal rescue of transforming growth factor-β1 null mice. Science 264: 1936–1938.
   PubMed Web of Science ®Google Scholar
• Li, J.-M., M. A. Nichols, S. Chandrasekharan, Y. Xiong, and X.-F. Wang 1995. Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270: 26750–26753.
   PubMed Web of Science ®Google Scholar
• Lyons, R. M., and H. L. Moses 1990. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187: 467–473.
   PubMedGoogle Scholar
• Massague, J. 1990. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6: 597–641.
   PubMedGoogle Scholar
• Miyamoto, S., P. J. Chiao, and I. M. Verma 1994. Enhanced IκB alpha degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines. Mol. Cell. Biol. 14: 3276–3282.
   PubMedGoogle Scholar
• Miyamoto, S., M. Maki, M. J. Schmitt, M. Hatanaka, and I. M. Verma 1994. Tumor necrosis factorα-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc. Natl. Acad. Sci. USA 91: 12740–12744.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., and I. M. Verma 1995. Rel/NF-κB/IκB story. Adv. Cancer Res. 66: 255–292.
   PubMed Web of Science ®Google Scholar
• Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773–785.
   PubMed Web of Science ®Google Scholar
• Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523–527.
   PubMed Web of Science ®Google Scholar
• Plevy, S. E., J. H. Gemberling, S. Hsu, A. J. Dorner, and S. T. Smale 1997. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17: 4572–4588.
   PubMed Web of Science ®Google Scholar
• Ristow, H. J. 1986. BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc. Natl. Acad. Sci. USA 83: 5531–5533.
   PubMedGoogle Scholar
• Roberts, A. B., and M. B. Sporn 1990. The transforming growth factor-β Handbook of experimental pharmacology, peptide growth factors and their receptors. In: Sporn, M. B., and A. B. Roberts419–472Springer, Heidelberg, Germany.
   Google Scholar
• Rook, A. H., J. H. Kehrl, L. M. Wakefield, A. B. Roberts, M. B. Sporn, D. B. Burlington, H. C. Lane, and A. S. Fauci 1986. Effects of transforming growth factor-β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136: 3916–3920.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis 1989. Molecular cloning: a laboratory manual2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Schmitz, M. L., and P. A. Baeuerle 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10: 3805–3817.
   PubMed Web of Science ®Google Scholar
• Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175: 1181–1194.
   PubMed Web of Science ®Google Scholar
• Shukla, R. R., A. Kumar, and P. L. Kimmel 1993. Transforming growth factor beta increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int. 44: 1022–1029.
   PubMed Web of Science ®Google Scholar
• Shull, M. M., I. Ormbsy, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693–699.
   PubMed Web of Science ®Google Scholar
• Sporn, M. B., and A. B. Roberts 1992. Transforming growth factor-beta: recent progress and new challenges. J. Cell Biol. 119: 1017–1021.
   PubMed Web of Science ®Google Scholar
• Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan 1988. Deactivation of macrophages by transforming growth factor-β. Nature 334: 260–262.
   PubMed Web of Science ®Google Scholar
• Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Berma 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787–789.
   PubMed Web of Science ®Google Scholar
• Wahl, S. M., J. B. Allen, N. McCartney-Francis, M. C. Morganti-Kossmann, T. Kossmann, L. Ellingsworth, U. E. Mai, S. E. Mergenhagen, and J. M. Orenstein 1991. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173: 981–991.
   PubMedGoogle Scholar
• Wang, C. Y., M. W. Mayo, Baldwin A. S., Jr. 1996. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784–787.
   PubMed Web of Science ®Google Scholar
• Wrann, M., S. Bodmer, R. de Martin, C. Siepl, R. Hofer-Warbinek, K. Frei, and E. Hofer 1987. T cell suppressor factor from human glioblastoma cells is a 12.5 kd protein closely related to transforming growth factor-beta. EMBO J. 6: 1633–1636.
   PubMed Web of Science ®Google Scholar
• Wu, R.-L., T.-T. Chen, and T.-T. Sun 1994. Functional importance of an Sp1- and an NFκB-related nuclear protein in a keratinocyte-specific promoter of rabbit K3 deratin gene. J. Biol. Chem. 269: 28450–28459.
   PubMedGoogle Scholar
• Zhong, H., H. SuYang, H. Erdjument-Bromage, P. Tempst, and S. Ghosh 1997. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413–424.
   PubMed Web of Science ®Google Scholar